These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4988185)

  • 1. [Problems concerning live measles vaccine and the control over its safety].
    Polna I
    Przegl Epidemiol; 1970; 24(1):21-30. PubMed ID: 4988185
    [No Abstract]   [Full Text] [Related]  

  • 2. The problem of active immunization against measles.
    Chumakov MP
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):381-8. PubMed ID: 4975393
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current problems in measles. II. Measles vaccines--recent progress].
    Ciufecu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):259-78. PubMed ID: 6438773
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitization of guinea-pigs to measles vaccines.
    Aprile MA; Kadar D; Wilson S
    Clin Exp Immunol; 1969 Nov; 5(5):531-9. PubMed ID: 4982816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live measles vaccine from a further attenuated strain SEVAC.
    Mares I; Drevo M; Adam E; Kubátová M; Casny J
    Prog Immunobiol Stand; 1967; 3():188-91. PubMed ID: 5379938
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells.
    Sasaki K
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):1-12. PubMed ID: 4217404
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):13-21. PubMed ID: 4476032
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of testing the effectiveness of live measles virus vaccine by using measles reference virus M1].
    Winkler D; Starke G; Patzwaldt HG; Plaga B
    Pharmazie; 1972 Sep; 27(9):606-8. PubMed ID: 5086359
    [No Abstract]   [Full Text] [Related]  

  • 9. [Scientific basis and experience with the large-scale production of live measles vaccine L-16].
    Andzhaparidze OG; Dorofeev VM; Kolianova IS; Martslina TG; Sokolova TM
    Vopr Virusol; 1969; 14(1):13-8. PubMed ID: 5795673
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of host-incorporated antigens in the immune response to measles virus.
    Isacson P
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:139-45. PubMed ID: 4313661
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Specific prophylaxis in measles. I. Preparation of a vaccine with modified live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y
    Stud Cercet Inframicrobiol; 1966; 17(5):371-6. PubMed ID: 5964005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and immunologic observation on 2 lines of attenuated measles vaccine virus on passage in chick embryo tissue culture].
    Chun H; Tsu TC; Tseng KH; Chang ST; Wu WH
    Zhonghua Yi Xue Za Zhi; 1973 Nov; 11():661-3. PubMed ID: 4203046
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on further attenuated live measles vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain.
    Ueda S; Takahashi M; Minekawa Y; Ogino T; Suzuki N
    Biken J; 1970 Jun; 13(2):111-6. PubMed ID: 5528344
    [No Abstract]   [Full Text] [Related]  

  • 15. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 16. [Potency test of measles vaccines from inactivated viruses. II. Calculation by a new estimating formula].
    von Mettenheim AE
    Zentralbl Bakteriol Orig; 1968; 207(2):158-65. PubMed ID: 5744277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 18. [Elaboration of live measles vaccine technology on human embryo lung diploid cell culture L-68].
    Nechaeva EA; Kolokol'tsova TD; Kits IV; Zhilina NV; Sen'kina TIu; Usova SV; Iurchenko ND; Azaev MSh; Tsareva AA
    Vestn Ross Akad Med Nauk; 1998; (3):29-32. PubMed ID: 9608273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.